Matt CAL is the founder of ITeos Therapeutics. ITeos Therapeutics has raised $200M in total funding. Latest round: Series B. Based in Watertown, MA.
Matthew Gall is the CFO of iTeos Therapeutics, an immuno-oncology company developing cancer immunotherapies. The company has raised over $200M in financing. Prior to iTeos, Gall was the Senior Vice President of Corporate Development and Treasurer at Sarepta Therapeutics, where he led a multi-billion dollar partnership with Roche and helped raise over $2 billion in capital. He also held roles in financial management and business development at Celgene Corporation and Gilead Sciences.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide